Weigh Thrombolytic Pros and Cons for Submassive Pulmonary Embolism

September 2018

We're getting questions about using SYSTEMIC thrombolytics to treat "submassive," or intermediate-risk, pulmonary embolism (PE).

We know to give a systemic thrombolytic for most hemodynamically unstable, or "massive," PE patients...and to hold off for mild PEs.

But those in the middle are trickier. "Submassive" PE patients have systolic BP above 90 mmHg but right ventricular dysfunction on CT or echo...or elevated troponins or BNP.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote